Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Endourol ; 21(9): 951-6, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17941767

RESUMEN

BACKGROUND AND PURPOSE: To assess the results of shockwave lithotripsy (SWL) for renal calculi in upper, middle, and lower calices according to the stone burden. PATIENT AND METHODS: A series of 52 female and 66 male patients with a mean age of 47.8 years and isolated single caliceal stones who underwent SWL monotherapy were enrolled. Stone burden, stone location, number of sessions/shockwaves, and auxiliary procedures were noted for each patient. Stones were located in the upper, middle, and lower calices of 35, 43, and 40, patients respectively, with mean stone burdens of 81.4 mm2, 75.2 mm2, and 96.3 mm2, respectively. Patients were evaluated with intravenous urography, plain film, or ultrasonography. Success was determined 3 months after the last session. Re-treatment rates were calculated. The effect of anatomic factors on the success of treatment for lower-caliceal stones also was determined. RESULTS: The mean stone burden, median number of treatment sessions, and mean number of shockwaves were 84.2 mm2, 2, and 4344, respectively. The auxiliary procedure rate was 16.1%, and the re-treatment rate was 71.2%. Failure was noted in 26 patients (22%). The stone-free rates for stones in the upper, middle, and lower calices were 82.8%, 83.4%, and 67.5%, respectively (P = 0.14). The stone-free rates for stones <100 mm2 and 100 to 200 mm2 were 91.2% and 65.5%, respectively (P = 0.001). The efficiency quotient was 49.8, 44.8, and 32.5 for upper-, middle-, and lower-caliceal stones, respectively. Infundibular length (P = 0.006) and infundibular width (P + 0.036) were significant in determining the stone-free rate after treatment of lower-caliceal stones. CONCLUSIONS: We recommend SWL as the first choice for treatment of stones <200 mm2 in the upper and middle calices. Extracorporeal lithotripsy is one of the options for lower-caliceal stones <200 mm2 but has high re-treatment and auxiliary-procedure rates in these cases.


Asunto(s)
Cálculos Renales/terapia , Cálices Renales/patología , Litotricia/métodos , Nefrología/métodos , Adulto , Femenino , Humanos , Cálices Renales/metabolismo , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Stents , Resultado del Tratamiento
2.
Int Urol Nephrol ; 33(1): 95-9, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12090348

RESUMEN

INTRODUCTION: Testicular sperm extraction (TESE) is well-defined procedure for surgical sperm retrieval in obstructive and non-obstructive azoospermia. This study was focused on the effectiveness of testicular sperm extraction and intracytoplasmic sperm injection (ICSI) for azoospermic men with different female age subgroups. MATERIALS AND METHODS: A total of 107 men with azoospermia underwent TESE and ICSI treatment. The women were examined in three groups 20-29, 30-34 and 35 years or older. The main outcome in this study was fertilization and pregnancy rates with TESE and ICSI. RESULTS: Spermatozoa were successfully retrieved during 97 of 107 (90.7%) TESE attempts, resulting in the fertilization of 286 of 563 (50.4%) injected metaphase II oocytes. Two hundred and fifty-five of them were transferred (89.8%). The clinical pregnancy rate and ongoing pregnancy rate per embryo transfer were 22.5% and 20.6% respectively. When comparing the fertilization and pregnancy rates, it was observed that women between the ages of 20-29 years had significantly higher pregnancy rates than women over 34 years of age (p < 0.05). CONCLUSION: The female age is a major factor in determining successful implantation in ICSI.


Asunto(s)
Transferencia de Embrión , Infertilidad Femenina/terapia , Edad Materna , Oligospermia/diagnóstico , Índice de Embarazo , Inyecciones de Esperma Intracitoplasmáticas/métodos , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Embarazo , Pruebas de Embarazo , Probabilidad , Estudios Prospectivos , Medición de Riesgo , Resultado del Tratamiento
3.
Turk J Med Sci ; 44(4): 681-6, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25551942

RESUMEN

BACKGROUND/AIM: To investigate whether autonomic nervous system (ANS) hyperactivity may be a potential cause for the relationship between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED). MATERIALS AND METHODS: Twenty-four patients were recruited for this study. Complete physical examinations, urine analysis, uroflowmetry, and postvoid residual urine volume (PVRU) analysis were performed. The potential impact of some factors such as hyperglycemia, obesity, and hyperlipidemia were analyzed. These values were correlated with the various symptom scores. We performed an electromyographic and an electrocardiographic evaluation. The alterations after treatment with 2 different alpha-blockers were also analyzed. RESULTS: The electromyographic and electrocardiographic assessments revealed a minimal increase in ANS activity and it did not change significantly after treatment (P > 0.05). After treatment, maximum flow rate increased and PVRU decreased significantly (P < 0.001 and P < 0.001, respectively); total and free testosterone levels increased significantly (P = 0.0068 and P = 0.0071, respectively). There was a statistically significant difference between the 2 treatment groups regarding the outcomes of the Danish Prostate Symptom Score questionnaire (P = 0.047). CONCLUSION: This current study suggested that the effect of ANS hyperactivity is not the fundamental factor underlying the relationship between LUTS and ED.


Asunto(s)
Sistema Nervioso Autónomo/fisiopatología , Disfunción Eréctil/complicaciones , Síntomas del Sistema Urinario Inferior/complicaciones , Hiperplasia Prostática/complicaciones , Antagonistas de Receptores Adrenérgicos alfa 1/farmacología , Anciano , Sistema Nervioso Autónomo/efectos de los fármacos , Glucemia/metabolismo , Índice de Masa Corporal , Disfunción Eréctil/sangre , Disfunción Eréctil/fisiopatología , Humanos , Lípidos/sangre , Síntomas del Sistema Urinario Inferior/sangre , Síntomas del Sistema Urinario Inferior/fisiopatología , Masculino , Persona de Mediana Edad , Hiperplasia Prostática/sangre , Hiperplasia Prostática/fisiopatología , Quinazolinas/farmacología , Factores de Riesgo , Sulfonamidas/farmacología , Tamsulosina , Testosterona/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA